CEM-CM3

This line was derived from CCRF-CEM by selecting for resistance to 8-azaguanine; The line has been used as a fusion partner in the production of human-human T cell hybridomasTumorigenecity: Isoenzyme: Histopathology: leukemia, acute lymphoblasticSubculture: Split ratio: Media change: Reverse transcritase: Production.